Fleury Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 5/6
Fleury verzeichnete einen durchschnittlichen jährlichen Gewinnzuwachs von 7.8%, während die Gewinne der Branche Healthcare jährlich um gewachsen und zwar um 12.9%. Die Umsätze verzeichneten einen durchschnittlichen jährlichen Gewinnzuwachs von gewachsen von 19.5%. Die Eigenkapitalrendite von Fleury beträgt 9.5% und die Nettomargen betragen 7%.
Wichtige Informationen
7.8%
Wachstumsrate der Gewinne
1.4%
EPS-Wachstumsrate
| Healthcare Wachstum der Industrie | 11.6% |
| Wachstumsrate der Einnahmen | 19.5% |
| Eigenkapitalrendite | 9.5% |
| Netto-Marge | 7.0% |
| Nächste Ertragsaktualisierung | 08 Aug 2024 |
Jüngste Aktualisierungen vergangener Leistungen
Recent updates
We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt
Jun 18
The Price Is Right For Fleury S.A. (BVMF:FLRY3)
Apr 16Concerns Surrounding Fleury's (BVMF:FLRY3) Performance
Mar 14Earnings Tell The Story For Fleury S.A. (BVMF:FLRY3)
Jan 05Fleury (BVMF:FLRY3) Has A Pretty Healthy Balance Sheet
Oct 05Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?
Jun 27We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt
Feb 25At R$18.27, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?
Sep 26Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?
Sep 08Fleury (BVMF:FLRY3) Has Some Way To Go To Become A Multi-Bagger
Jul 01When Should You Buy Fleury S.A. (BVMF:FLRY3)?
Jun 10Is Fleury (BVMF:FLRY3) Using Too Much Debt?
Apr 10Return Trends At Fleury (BVMF:FLRY3) Aren't Appealing
Mar 24At R$19.12, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?
Feb 08Returns On Capital Are Showing Encouraging Signs At Fleury (BVMF:FLRY3)
Dec 08Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly
Nov 05Is Fleury S.A. (BVMF:FLRY3) Potentially Undervalued?
Oct 21Investors Should Be Encouraged By Fleury's (BVMF:FLRY3) Returns On Capital
Aug 24Fleury (BVMF:FLRY3) Seems To Use Debt Rather Sparingly
Jul 31Is It Time To Consider Buying Fleury S.A. (BVMF:FLRY3)?
Jul 07Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?
Apr 30Fleury (BVMF:FLRY3) Shareholders Will Want The ROCE Trajectory To Continue
Apr 12At R$25.16, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?
Mar 29Should You Or Shouldn't You: A Dividend Analysis on Fleury S.A. (BVMF:FLRY3)
Mar 16Only One Day Left To Cash In On Fleury's (BVMF:FLRY3) Dividend
Mar 01Fleury S.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Feb 28What Type Of Shareholders Make Up Fleury S.A.'s (BVMF:FLRY3) Share Registry?
Feb 15Shareholders of Fleury (BVMF:FLRY3) Must Be Delighted With Their 360% Total Return
Feb 02
Three Days Left To Buy Fleury S.A. (BVMF:FLRY3) Before The Ex-Dividend Date
Jan 03Should We Be Excited About The Trends Of Returns At Fleury (BVMF:FLRY3)?
Dec 28Would Fleury S.A. (BVMF:FLRY3) Be Valuable To Income Investors?
Dec 12Taking A Look At Fleury S.A.'s (BVMF:FLRY3) ROE
Nov 29Getting In Cheap On Fleury S.A. (BVMF:FLRY3) Might Be Difficult
Aug 30Here's What You Should Know About Fleury S.A.'s (BVMF:FLRY3) 3.8% Dividend Yield
Aug 18Can Fleury S.A. (BVMF:FLRY3) Improve Its Returns?
Aug 03Could The Fleury S.A. (BVMF:FLRY3) Ownership Structure Tell Us Something Useful?
Jul 22Is Now The Time To Look At Buying Fleury S.A. (BVMF:FLRY3)?
Jul 10Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?
Jun 25Aufschlüsselung der Einnahmen und Ausgaben
Wie Fleury Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
| Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
|---|---|---|---|---|
| 31 Mar 24 | 7,138 | 498 | 888 | 0 |
| 31 Dec 23 | 6,471 | 424 | 827 | 0 |
| 30 Sep 23 | 5,881 | 373 | 751 | 0 |
| 30 Jun 23 | 5,158 | 295 | 661 | 0 |
| 31 Mar 23 | 4,610 | 291 | 530 | 0 |
| 31 Dec 22 | 4,463 | 308 | 498 | 0 |
| 30 Sep 22 | 4,366 | 348 | 534 | 0 |
| 30 Jun 22 | 4,248 | 347 | 551 | 0 |
| 31 Mar 22 | 4,069 | 342 | 514 | 0 |
| 31 Dec 21 | 3,873 | 350 | 481 | 0 |
| 30 Sep 21 | 3,783 | 419 | 399 | 0 |
| 30 Jun 21 | 3,629 | 456 | 335 | 0 |
| 31 Mar 21 | 3,151 | 317 | 316 | 0 |
| 31 Dec 20 | 2,972 | 257 | 321 | 0 |
| 30 Sep 20 | 2,764 | 174 | 309 | 0 |
| 30 Jun 20 | 2,645 | 133 | 325 | 0 |
| 31 Mar 20 | 2,918 | 278 | 330 | 0 |
| 31 Dec 19 | 2,905 | 312 | 320 | 0 |
| 30 Sep 19 | 2,840 | 314 | 314 | 0 |
| 30 Jun 19 | 2,767 | 314 | 296 | 0 |
| 31 Mar 19 | 2,712 | 328 | 297 | 0 |
| 31 Dec 18 | 2,664 | 332 | 296 | 0 |
| 30 Sep 18 | 2,592 | 338 | 281 | 0 |
| 30 Jun 18 | 2,524 | 334 | 275 | 0 |
| 31 Mar 18 | 2,449 | 335 | 267 | 0 |
| 31 Dec 17 | 2,383 | 321 | 257 | 0 |
| 30 Sep 17 | 2,324 | 331 | 260 | 0 |
| 30 Jun 17 | 2,248 | 307 | 257 | 0 |
| 31 Mar 17 | 2,176 | 266 | 249 | 0 |
| 31 Dec 16 | 2,096 | 229 | 243 | 0 |
| 30 Sep 16 | 2,046 | 180 | 233 | 0 |
| 30 Jun 16 | 2,002 | 152 | 229 | 0 |
| 31 Mar 16 | 1,956 | 139 | 224 | 0 |
| 31 Dec 15 | 1,895 | 107 | 222 | 0 |
| 30 Sep 15 | 1,845 | 94 | 224 | 0 |
| 30 Jun 15 | 1,801 | 90 | 216 | 0 |
| 31 Mar 15 | 1,730 | 73 | 209 | 0 |
| 31 Dec 14 | 1,679 | 86 | 209 | 0 |
| 30 Sep 14 | 1,646 | 73 | 206 | 0 |
| 30 Jun 14 | 1,634 | 60 | 215 | 0 |
| 31 Mar 14 | 1,659 | 66 | 223 | 0 |
| 31 Dec 13 | 1,657 | 61 | 216 | 0 |
| 30 Sep 13 | 1,643 | 78 | 211 | 0 |
| 30 Jun 13 | 1,603 | 86 | 211 | 0 |
Qualität der Erträge: FLRY3 hat hohe Qualitätseinkünfte.
Wachsende Gewinnspanne: FLRY3Die aktuellen Gewinnspannen (7%) sind höher als im letzten Jahr (6.3%).
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: FLRY3In den letzten 5 Jahren sind die Gewinne von 7.8% jährlich gestiegen.
Beschleunigtes Wachstum: FLRY3Das Gewinnwachstum des Unternehmens im letzten Jahr (70.9%) übertrifft seinen 5-Jahres-Durchschnitt (7.8% pro Jahr).
Erträge im Vergleich zur Industrie: FLRY3 Das Gewinnwachstum im vergangenen Jahr (70.9%) übertraf das der Branche Healthcare 63.3% .
Eigenkapitalrendite
Hohe Eigenkapitalrendite: FLRY3Die Eigenkapitalrendite des Unternehmens (9.5%) wird als niedrig angesehen.